Table 7 Lifetime attributable risk (LAR) for five patients
Organ | Modality\ID | LAR* | ||||
|---|---|---|---|---|---|---|
| Â | Â | 1 | 2 | 3 | 4 | 5 |
Lung | IMRT | 4.1 | 3.3 | 6.9 | 220.4 | 18.0 |
| Â | VMAT | 4.3 | 3.4 | 7.7 | 244.3 | 22.5 |
| Â | TOMO | 56.4 | 72.6 | 89.6 | 277.9 | 135.3 |
Stomach | IMRT | 27.4 | 46.5 | 34.7 | 73.0 | 102.9 |
| Â | VMAT | 27.5 | 46.9 | 34.7 | 73.0 | 165.1 |
| Â | TOMO | 27.5 | 47.3 | 34.7 | 73.0 | 79.5 |
Normal liver | IMRT | 18.5 | 24.2 | 22.1 | 17.2 | 34.4 |
| Â | VMAT | 18.5 | 24.1 | 22.2 | 17.9 | 35.5 |
| Â | TOMO | 19.5 | 28.7 | 23.4 | 18.8 | 17.8 |
Small intestine | IMRT | 14.5 | 9.5 | 23.9 | 58.4 | 15.1 |
| Â | VMAT | 13.6 | 10.6 | 24.4 | 58.1 | 21.6 |
| Â | TOMO | 15.0 | 7.7 | 23.8 | 100.5 | 12.6 |
Prostate/Ovary | IMRT | 0.2 | 0.2 | 0.2 | 7.4 | 2.5 |
| Â | VMAT | 0.1 | 0.1 | 0.2 | 6.0 | 2.4 |
| Â | TOMO | 0.2 | 0.1 | 0.2 | 5.5 | 2.0 |
Rectum | IMRT | 3.8 | 2.8 | 5.9 | 14.6 | 4.4 |
| Â | VMAT | 3.1 | 2.3 | 4.9 | 11.7 | 4.5 |
| Â | TOMO | 3.7 | 2.3 | 4.5 | 11.5 | 3.6 |